1. Home
  2. NVCR vs ESRT Comparison

NVCR vs ESRT Comparison

Compare NVCR & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • ESRT
  • Stock Information
  • Founded
  • NVCR 2000
  • ESRT 2011
  • Country
  • NVCR Switzerland
  • ESRT United States
  • Employees
  • NVCR N/A
  • ESRT N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • ESRT Real Estate Investment Trusts
  • Sector
  • NVCR Health Care
  • ESRT Real Estate
  • Exchange
  • NVCR Nasdaq
  • ESRT Nasdaq
  • Market Cap
  • NVCR 1.4B
  • ESRT 1.2B
  • IPO Year
  • NVCR 2015
  • ESRT 2013
  • Fundamental
  • Price
  • NVCR $14.04
  • ESRT $7.78
  • Analyst Decision
  • NVCR Buy
  • ESRT Hold
  • Analyst Count
  • NVCR 7
  • ESRT 2
  • Target Price
  • NVCR $28.79
  • ESRT $10.65
  • AVG Volume (30 Days)
  • NVCR 1.9M
  • ESRT 1.5M
  • Earning Date
  • NVCR 10-30-2025
  • ESRT 10-29-2025
  • Dividend Yield
  • NVCR N/A
  • ESRT 1.81%
  • EPS Growth
  • NVCR N/A
  • ESRT N/A
  • EPS
  • NVCR N/A
  • ESRT 0.24
  • Revenue
  • NVCR $630,160,000.00
  • ESRT $763,746,000.00
  • Revenue This Year
  • NVCR $6.68
  • ESRT $2.27
  • Revenue Next Year
  • NVCR $7.01
  • ESRT $3.04
  • P/E Ratio
  • NVCR N/A
  • ESRT $32.38
  • Revenue Growth
  • NVCR 14.58
  • ESRT 1.14
  • 52 Week Low
  • NVCR $10.87
  • ESRT $6.56
  • 52 Week High
  • NVCR $34.13
  • ESRT $11.62
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 60.46
  • ESRT 55.39
  • Support Level
  • NVCR $12.61
  • ESRT $7.72
  • Resistance Level
  • NVCR $14.77
  • ESRT $7.87
  • Average True Range (ATR)
  • NVCR 0.55
  • ESRT 0.16
  • MACD
  • NVCR 0.19
  • ESRT 0.02
  • Stochastic Oscillator
  • NVCR 67.68
  • ESRT 82.57

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About ESRT Empire State Realty Trust Inc.

Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.

Share on Social Networks: